Following its secretion from cytotoxic lymphocytes into the immune synapse, perforin binds to target cell membranes through its Ca 2 + -dependent C2 domain. Membrane-bound perforin then forms pores that allow passage of pro-apoptopic granzymes into the target cell. In the present study, structural and biochemical studies reveal that Ca 2 + binding triggers a conformational change in the C2 domain that permits four key hydrophobic residues to interact with the plasma membrane. However, in contrast with previous suggestions, these movements and membrane binding do not trigger irreversible conformational changes in the pore-forming MACPF (membrane attack complex/perforinlike) domain, indicating that subsequent monomer-monomer interactions at the membrane surface are required for perforin pore formation.
INTRODUCTION
The pore-forming protein, PRF (perforin; PRF1 gene), is stored and secreted by cytotoxic lymphocytes [CTLs (cytotoxic Tlymphocytes) and natural killer cells] and is essential for the successful elimination of virus-infected or oncogenic cells [1] . During an immune response, cytotoxic lymphocytes form an immune synapse with a target cell, and subsequently release PRF monomers and pro-apoptotic serine proteases (granzymes) into the synaptic cleft [2] . Subsequent interaction with target cell membranes results in PRF oligomerization into transmembrane pores, which facilitates the entry of granzymes to initiate apoptosis [3, 4] . Carriers of bi-allelic mutations in the PRF1 gene lack cytotoxic lymphocyte function and develop an aggressive immunoregulatory disorder, familial haemophagocytic lymphohistiocytosis (type II FHL) [5] or haematological malignancies [6] .
PRF consists of an N-terminal MACPF (membrane attack complex/PRF-like) domain [7] [8] [9] and a central EGF (epidermal growth factor)-containing 'shelf-like' structure, beneath which is positioned a Ca 2 + -dependent C2 domain [9] . The C2 domain is crucial for PRF function, and it governs initial interactions with the target cell membrane in a Ca 2 + -dependent fashion. Following membrane binding, PRF oligomerizes, and two membranespanning regions (termed TMH1 and TMH2) in the MACPF domain are released and penetrate the lipid membrane. The resulting pore typically comprises 20-22 PRF molecules, with each PRF monomer contributing two β-hairpins to a giant membrane-spanning β-barrel [9, 10] .
The PRF C2 domain is unusual in that it has a relatively low affinity (∼ 200 μM) for Ca 2 + in comparison with homologous C2 domains that function inside the cell [11] . This feature probably represents an important control point, and helps ensure that PRF does not attack the cell from inside, before its release from secretory granules into the immune synapse. Although membrane binding is clearly a prerequisite for the formation of PRF pores, the exact mechanism and role of Ca 2 + -dependent C2 domain interaction with the membrane has not been characterized. It also remains unclear whether membrane binding of PRF represents a trigger for PRF unfolding and insertion into the phospholipid bilayer of the target cell membrane.
In the present study, we investigated the mechanism of Ca 2 + -dependent PRF C2 domain membrane binding. We found that Ca 2 + co-ordination by the C2 domain induced conformational changes that significantly stabilized monomeric PRF. This was a prerequisite for subsequent hydrophobic interactions with the plasma membrane and positioning of monomeric PRF such that it favoured pore formation. Furthermore, we showed that initial interactions between PRF, Ca 2 + and the plasma membrane did not trigger either oligomerization or irreversible conformational change within the MACPF domain.
As described previously, mouse WT (wild-type) and mutant recombinant PRF were expressed and purified, and activity was assessed using SRBC (sheep red blood cell) (Department of Veterinary Sciences, The University of Melbourne) lysis and 51 Cr release assays [12] . The binding and oligomerization efficiency of PRF was determined as described previously [15] , by incubating PRF and SRBCs in a neutral HE buffer (10 mM Hepes and 150 mM NaCl, pH 7) with 1 mM Ca 2 + at either 4 • C or 37
• C for 15 min. To determine the proportion of monomeric PRF that had oligomerized into SDS-resistant complexes, 8 M urea was added to the sample buffer [15] . Thermal stability of WT and mutant PRF was assessed by unfolding temperature analysis using SYPRO ® Orange as described in [3, 4] .
Analytical ultracentrifugation of PRF
Sedimentation velocity experiments were conducted in a Beckman model XL-A analytical ultracentrifuge at a temperature of 20
• C. A 380 μl sample (0.253 mg/ml) and 400 μl of reference solution (50 mM Tris, 300 mM NaCl, 10 % glycerol and 0.02 % azide, pH 7.2) were loaded into a conventional double sector quartz cell and mounted in a Beckman four-hole An-60 Ti rotor. Samples were centrifuged at a rotor speed of 40 000 rev./min and the data were collected continuously at a single wavelength (280 nm), using a step-size of 0.003 cm without averaging. Solvent density (1.015 g/ml) and viscosity [1.070 cP (1 poise = 10 − 1 N·s·m − 2 )], as well as estimates of the partial specific volume (0.719 ml/g) and hydration estimate (0.388 g/g) at 20
• C were computed using the program SEDNTERP [16] . Sedimentation velocity data at multiple time points were fitted to a continuous sedimentation coefficient [c(s)] distribution and a continuous mass [c(M)] distribution model [17, 18] using the program SEDFIT, at a resolution of 200, with M min = 1 kDa, M max = 150 kDa and at a confidence level (F-ratio) = 0.95. SEDFIT is available to download from the following website: http://www.analyticalultracentrifugation.com.
Cytotoxicity assays
The QuikChange ® site-directed mutagenesis system was used to generate point mutations in mouse WT PRF cDNA, which were cloned into the pIRES-EGFP expression plasmid (Biosciences Clontech). As described earlier, mouse WT and mutant PRF plasmids were transiently transfected in RBL cells [11] and primary CTLs of Prf1 − / − .OT-1 C57BL/6 mice [13] and sorted for equal mean GFP fluorescence with subsequent assessment of cytotoxic activity in 51 Cr release assays [11] .
Electrophoresis and immunoblotting
Cell lysates, SRBC membranes and purified recombinant PRF were resolved on SDS/PAGE (9 %) Tris/glycine gels and analysed for PRF expression by immunoblotting with rat anti-(mouse PRF) mAb (monoclonal antibody) P1-8 [19] followed by secondary HRP (horseradish peroxidase)-linked anti-(rat Ig) antibody (Dako). Mouse anti-(human actin) mAb (Sigma) followed by secondary HRP-linked anti-(mouse Ig) (Dako) was used as a loading control for cell lysates. Signals were amplified by chemiluminescence and detected on X-ray film (GE Healthcare).
Confocal microscopy
RBL cells transiently transfected with mouse WT and mutant PRF cDNA were fixed in ice-cold methanol and processed and imaged as described previously [20] . PRF was detected using a primary mouse anti-PRF mAb (clone 6G7/1F10) [21] 
Protein expression and purification of SmC2P1
A DNA sequence encoding the SmC2P1 (without the signal peptide) was purchased from Top Gene Technology and cloned into pAPG110 for storage. The SmC2P1 gene was amplified using PCR with the following oligonucleotides: 5 -CGAATTCCCATA-TGCAGCTGCGTCTGTATAATCTGCG-3 and 5 -GCATTAT-ATGTATACCCTGAGCGTGTAAGGATCCAAGCTTCG-3 and cloned into a modified version of the Escherichia coli expression vector pCOLD IV (Takara Bio). The pCOLD IV plasmid was modified by restriction enzyme digest, first using NdeI and HindIII to excise and allow ligation of the HisTev/maspin encoding sequence from pHisTev/maspin [22] . Secondly, EcoRI and HindIII restriction enzymes were used to excise the fulllength maspin gene. Finally, the SmC2P1 gene was ligated via EcoRI and HindIII restriction sites into the resulting plasmid, pCOLDIVHisTev/SmC2P1. This plasmid encodes an N-terminal His 6 tag linked to the SmC2P1 cDNA via a Tev (tobacco etch virus) protease recognition site. Positive clones were confirmed by DNA sequencing and transformed into Rosetta Gami 2 (DE3)pLysS E. coli cells (EMD Millipore) for expression. The final amino acid sequence comprises an N-terminal tag (MRGSHHHHHHENLYFQGQNSHM) followed by residues 21-129 of SmC2P1. Rosetta Gami 2 (DE3)pLysS E. coli cells (EMD Millipore) were used as an expression host. Cells were grown in yeast/tryptone medium [1.6 % (w/v) tryptone, 1 % (w/v) yeast extract and 0.5 % NaCl] with 100 μg/ml ampicillin at 37
• C with shaking until D 600 reached 0.6-0.8. Expression was then induced by the addition of IPTG (1 mM final concentration) and growth continued overnight at 16
• C with shaking. Cells were harvested by centrifugation (8000 g, 20 min, 4
• C), resuspended in buffer A (50 mM Tris/HCl, pH 8.0, 50 mM NaCl, 10 % imidazole and 0.01 Triton X-100) containing a tablet of Complete TM protease inhibitor (Roche) and lysed by sonication. The lysate was clarified by centrifugation and the supernatant was subject to purification.
Purification of the His 6 -tagged SmC2P1 protein was achieved with three steps of chromatography columns. The lysate was first loaded on to a 1 ml HisTrap FF affinity column (GE Healthcare). The column was washed with five column volumes of buffer A and five column volumes of buffer B (50 mM Tris/HCl, pH 8.0, 500 mM NaCl and 25 % imidazole). The His 6 -tagged SmC2P1 protein finally eluted with buffer B containing 250 mM imidazole. Fractions containing the protein were concentrated and loaded on to a Superdex 200 16/60 gel filtration column pre-equilibrated with buffer C (50 mM Tris/HCl, pH 8.0, and 150 mM NaCl). Fractions from the gel filtration steps were pooled, and diluted 1:3 in 50 mM Tris/HCl, pH 8.0, and purified through a 5 ml HiTrap Q FF column (GE Healthcare). A salt gradient made of buffer C (50 mM Tris/HCl, pH 8.0, and 50 mM NaCl) and buffer D (50 mM Tris/HCl, pH 8.0, and 1 M NaCl) was used to elute the protein. The purity of the protein was assessed by SDS/PAGE.
Structural analysis of SmC2P1
The His 6 -tag purified protein was concentrated to 6 mg/ml and subject to crystallization trials. Initial screenings of the crystallization conditions were performed at the Monash University CrystalMation platform using the following screens: JCSG + (Qiagen), PEGion HT (Hampton Research) and Wizard Classic 1 and 2 (Emerald Bio). Crystallization plates were stored at 293 K and photographs were taken every day. Crystals appeared after 48 h in two conditions. Optimization was performed manually using the hanging-drop method. The best diffracting crystals were obtained in [100 mM Tris/HCl, pH 8. Before data collection, crystals were soaked in a solution containing the crystallization mother liquor with 25 % glycerol for cryo-protection. Crystals were flash cooled in liquid nitrogen and data collected at 100 K. Screening for the best diffracting crystal was carried out in-house on a Rigaku MicroMax-007 HF rotating anode mounted with a RAXIS IV + + image plate. Diffraction data were then collected either in-house or on the MX1 beamline of the Australian Synchrotron. The data collection strategy consisted of a full scan (>180
• ) on the crystal with 1
• oscillation range. Exposure time was 60 s in-house and 1 s at the synchrotron. Data were indexed and integrated with XDS [23] and intensities scaled with SCALA [24] . Data collection statistics are summarized in Table 1 . The Matthews coefficient and estimation of solvent content of the crystals was carried out in CCP4 [25] . Crystals of ApoSmC2P1 belong to the space group C2 with unit cell parameter a = 25. The structures were determined at 1.60 Å (R = 20.89 %; R free = 23.94 %) and 1.66 Å (R = 14.75 %; R free = 17.18 %) respectively for apoSmC2P1 and CaSmC2P1. The structure of both proteins were determined using molecular replacement as deployed in PHASER using the co-ordinates of the PRF C2 domain (residues 413-525) as a search probe. Refinement was carried out using REFMAC and PHENIX. Structure factors and final models are available in the PDB under accession codes 3W56 and 3W57. Data collection and refinement statistics are summarized in Table 1 .
Table 1 Statistics for X-ray data collection and refinement for SmC2P1
Value in parentheses refer to the highest resolution shell. R merge = hkl i |I i (hkl) − <I(hkl)> |/ hkl i I i (hkl), where I i (hkl) is the intensity of individual reflections. R pim is the multiplicityweighted R merge . R work = (|F o | − |F c |)/|F c |. R free was calculated using 5 % of randomly selected reflection, excluded from the refinement.
Parameters
CaSmC2P1 apoSmC2P1 
Statistical analysis
An unpaired Student's t test was used to compare two groups of samples, and a one-way ANOVA with Newman-Kuels post-test analysis was used to compare more than two groups of samples.
RESULTS

PRF is stabilized by Ca 2 + binding
In 2010, we determined the structure of monomeric PRF [9] . In addition to identifying the overall architecture of the molecule, our data revealed the presence of two Ca 2 + atoms bound to the C2 domain [9] . ). These ions were presumably scavenged during purification, as no Ca 2 + was added to the crystallization buffers, and thus were likely to be tightly bound.
Through comparison with known C2 domains and owing to a requirement for high-micromolar concentration of Ca 2 + for PRF membrane binding and pore-forming activity, we concluded that one or two lower affinity CBRs remained vacant (different types of C2 domains bind different numbers of Ca 2 + atoms). Unexpectedly, our structural data revealed that Asp 429 , an invariantly conserved residue that is essential for Ca 2 + -dependent membrane binding of PRF [11] was located >8 Å
Figure 1 Prediction for the calcium-induced structural reorganization of PRF C2 domain
PRF C2 domain backbone (magenta) and the density map (white) are based on [9] distal from the core CBR and could not possibly co-ordinate Ca 2 + in this position [9] . Accordingly, it was suggested that engagement of Asp 429 in Ca 2 + binding could only occur through major rearrangement in the C2 domain, leading to significant repositioning of Asp 429 ( Figure 1 ). We therefore predicted that Ca 2 + -induced conformational change would position the PRF C2 domain into a thermodynamically favourable and stable conformation, as has been demonstrated for other Ca 2 + -binding proteins [26] .
To investigate the global effect of Ca 2 + on PRF, we first examined the thermal stability of WT PRF. As expected [4] , at physiological concentrations of Ca 2 + ( 1 mM), purified PRF acquired a more stable conformation, as detected by a significant increase in melting temperature (Figure 2A ). The increase in stability was at least partly attributed to the putative conformational change that occurred when residue Asp 429 of CBR1 co-ordinated Ca 2 + , as the melting temperature of the inactive, but structurally stable, D429A mutant [11] did not increase in the presence of Ca 2 + (Figure 2A) . Using analytical ultracentrifugation, we also discovered that, in contrast with previous studies [27] , PRF maintained its monomeric structure in solution in the presence of Ca 2 + and did not aggregate ( Figure 2B ). Taken together, these data suggested that the conformational change that occurred through Ca 2 + co-ordination in the C2 domain of PRF stabilized the monomer, but did not trigger oligomerization in solution. We next examined the consequence of Ca 2 + -induced conformational changes in the C2 domain on PRF activity in the presence of a phospholipid bilayer.
Hydrophobic residues at the tip of the PRF C2 domain are required for efficient interaction with membranes
The CBRs of PRF include two pairs of conserved and exposed aromatic side chains at the tip of the C2 domain: hydrophobic residues Trp 427 and Tyr 430 (in CBR1), and Tyr 486 and Trp 488 (in CBR3), which we predicted would play a role in plasma membrane contact and binding [9] . We also noted that the topology of Trp 427 /Tyr 430 would be sub-optimal for membrane binding in apo-PRF, and predicted that these residues would be repositioned in response to Ca 2 + -induced conformational change of Asp 429 to face the membrane (Figure 1 ). In order to determine whether the four residues were involved in membrane binding, we engineered mutants with several combinations of amino acid substitutions and tested their cytotoxic function using effector-target cell-based RBL assays [12] . The mutation of all four residues, to alanine or serine residues (W427A/Y430A/Y486A/W488A and W427S/Y430S/Y486S/W488S; Figure 3A ) resulted in a complete loss of function, thus confirming that PRF activity was absolutely dependent on the presence of exposed aromatic side chains at the tip of the C2 domain. Even in the most physiological environment of cytotoxic lymphocytes, the quadruple mutants were unable to restore the activity of primary PRF-deficient cytotoxic T-cells from Prf1
− / − mice ( Figure 3E ). Quadruple substitutions did not affect protein folding, stability and intracellular localization, as shown by thermal melt experiments, Western immunoblotting and immunofluorescence microscopy ( Figures 3F and 4A) .
To test the significance of individual amino acids in CBR1 and CBR3, and identify the minimum number of aromatic side chains required to restore PRF to WT function, we generated a series of triple mutants. Figure 3B ). In comparison, leaving Tyr 486 intact (in the W427A/Y430A/W488A mutant) only rescued ∼ 1 % of activity ( Figure 3B ), suggesting that Tyr 486 played a less important role in PRF function than the other three residues. Next, we found that keeping the hydrophobic residues of either CBR1 or CBR3 intact was equally important for PRF function in the context of effector cells, as W427A/Y430A and Y486A/W488A had ∼ 50 % reduced activity compared with WT PRF (Figure 3C ). Mutation of an individual residue (i.e. W427A, Y430A, Y486A or W488A) had no effect on WT PRF activity ( Figure 3D ). Therefore maintaining a pair of residues within CBR1 or CBR3 (i.e. W427A/Y430A and Y486A/W488A) was critical for maintaining PRF function.
Our functional studies clearly showed that the exposed aromatic side chains at the tip of the C2 domain are important for PRF function. To determine whether this is due to interactions with the plasma membrane, we expressed and purified W427A/Y430A, Y486A/W488A and the quadruple mutant W427A/Y430A/Y486A/W488A. First, we tested whether the mutations influenced Ca 2 + -dependent stabilization of PRF, by investigating changes in the thermal stability of the PRF mutants. In contrast with the D429A mutant (Figure 2A ), W427A/Y430A/Y486A/W488A, as well as W427A/Y430A and Y486A/W488A, all gained thermodynamic stability in the presence of Ca 2 + (Figure 4A ), suggesting that these mutations did not influence Ca 2 + binding. Next, we investigated the in vitro cytotoxic activity of each mutant and found that all three purified PRF mutants had significantly less activity than WT PRF ( Figure 4B ), and bound inefficiently to membranes ( Figure 4C ). Furthermore, the CBR1 mutant (W427A/Y430A) had ∼ 4-fold less activity than the CBR3 mutant (Y486A/W488A) ( Figure 4B ). In agreement with this, W427A/Y430A bound less efficiently to the plasma membrane than the Y486A/W488A mutant, with more unbound recombinant protein detected in the supernatant ( Figure 4C ; see lane 2). Of note, the difference in function between the purified recombinant PRF and the cell-based assays for W427A/Y430A and Y486A/W488A is not an unusual observation. In the context of a cellular system, which requires recognition of a target cell and the formation of an immune synapse, the delivery of PRF to the target cell is polarized and concentrated. In addition, PRF may synergize with co-secreted proteases in cell-based assays. Taken together, this can lead to underestimation of functional defects in mutant PRF that have residual activity, as has been observed in the past [11] [12] [13] . By comparison, the recombinant quadruple mutant did not lyse target cells and was completely devoid of Ca 2 + -dependent membrane binding ( Figures 4B and 4C) , even though all of the essential Ca 2 + -binding aspartate residues within the C2 domain remained intact. These results clearly demonstrated that the two pairs of exposed aromatic side chains at the tip of the C2 domain had an essential role in PRF membrane binding. Our data strongly suggested that the conformational change of Asp 429 towards the Ca 2 + -binding pocket would position all four hydrophobic residues in the most favourable topology for membrane binding.
To investigate the effect of Ca 2 + on PRF structure directly, we initially attempted soaking murine PRF crystals in increasing concentrations (100-250 μM) of Ca 2 + . These experiments invariably resulted in crystal destruction, most likely because Asp 429 forms a key contact in the PRF crystal lattice [9] . Co-crystallization experiments in the presence of appropriate concentrations of Ca 2 + (100-250 μM) have also failed to yield suitable crystals. Moreover, extensive attempts over many years to produce the PRF C2 domain alone (using a variety of domain boundaries) have not yielded folded protein. This latter problem is unsurprising, since the PRF C2 domain has evolved to form a modest hydrophobic interface with the EGF/shelf region [9] . To understand how the PRF C2 domain functions, we decided to investigate whether related proteins could be used as a model system to study the PRF C2 domain.
Our previous results have shown that the PRF C2 domain is quite unusual, as it is a type II C2 domain that in terms of amino acid sequence is most similar to the type I C2 fold variant. Indeed, the most similar protein structurally characterized to date is 51 Cr release assay using Jurkat T-cells as targets, at the effector/target (E:T) ratios indicated. All values have been standardized against WT PRF at a 30:1 effector/target ratio (100 %; average maximum lysis was 51.2 + − 1.8 % S.E.M.), which has been duplicated in each graph for clarity. Each value represents means + − S.E.M. for three independent experiments for each hydrophobic mutant and of ten independent experiments for WT PRF, and statistics were obtained with a one-way ANOVA with Newman-Keuls multiple comparison test post-hoc analysis; *P < 0.
(E) Cytotoxic activity of transiently transfected CTLs of Prf1
− / − .OT-1 C57BL/6 mice expressing WT PRF and the quadruple hydrophobic-PRF mutant, as determined by 51 Cr release assay using SIINFEKL pulsed EL-4 cells as targets, at the effector/target ratios indicated and is representative of two independent experiments. Each value represents means + − S.E.M. and statistics were obtained with an unpaired two-sample for means t test; *P < 0.05. Munc13-C2B [9, 28] . This protein shares 35 % sequence identity, but importantly contains extensive insertions (including a large helical region) and deletions in the critical Ca 2 + /lipid-binding region. Thus known structures do not permit us to understand how many Ca 2 + atoms the PRF C2 domain is able to co-ordinate.
Neither do these structures allow us to study the extent of Ca 2 + -driven conformational change, or whether unique rearrangements could take place within the PRF C2 domain that, when considered in the context of the entire molecule, could be predicted to trigger a conformational change in the MACPF domain.
Figure 5 Sequence alignment of SmC2P1 and four PRF-like C2 domains
Bold and boxed amino acids indicate residues essential for Ca 2 + binding in PRF. The alignment was performed using ClustalW.
To address these questions, and in light of these problems, we therefore developed an alternative strategy to understand how the PRF C2 domain binds Ca 2 + . We conducted PSI-BLAST searches in order to identify the C2 domain most similar to PRF. These searches revealed a unique fish C2 domain-only protein in the Scophthalmus maximus [29] . This protein, which is termed SmC2P1, shares 39 % identity with the murine PRF C2 domain [29] (Figure 5 ) and contains all of the critical conserved residues implicated previously in Ca 2 + binding by PRF ( Figure 5 ). Crucially, we also noted that the lipid-binding loops were more similar to PRF than any other known C2 domain (structurally characterized or uncharacterized), and differed only by four amino acid insertions ( Figure 5) . Overall, the high sequence similarity led us to reason that it represented the most suitable model for confirming our findings in PRF.
A unique C2 domain-only protein SmC2P1 as a model for PRF C2 domain
We expressed SmC2P1 and crystallized the protein in the presence and absence of Ca 2 + . The 1.60 Å structure of apo-SmC2P1 ( Figures 6A-6C ) revealed the overall fold is very similar to that of the PRF C2 domain (0.536 Å deviation over 332 atoms; Figure 6C ). Indeed, Dali searches [30] confirmed that the SmC2P1 structure is more similar to PRF (z-score 17.8) than to any other structure determined to date. Unsurprisingly, the protein with the second highest similarity (z-score 16) was Munc13-C2B.
Although the structure of apo-PRF is unknown, we noted that the overall position and orientation of CBR2 and CBR3 were extremely similar in the two structures ( Figure 6C ). Thus the two Ca 2 + atoms already present in the PRF monomer did not seem to dramatically influence the overall structure of CBR2 and CBR3. In contrast, CBR1 in apo-SmC2P1, which contains the key residue Asp 35 (equivalent to Asp 429 in PRF) could not be resolved in electron density and was not modelled in the final structure. These data suggested that this region is mobile in the absence of Ca 2 + . Whereas CBR1 is visible in the PRF crystal structure, we noted that it makes significant crystal contacts that may influence or stabilize its conformation [9] . Interestingly, similar to PRF, SmC2P1 also underwent a large increase in thermal stability in the presence of Ca 2 + (results not shown) and its membrane-binding activity was strictly Ca 2 + -dependent (as shown by Zhao et al. [29] ).
We next determined the 1.66 Å structure of Ca 2 + -bound SmC2P1 ( Figures 6A, 6B and 6D-6F). These structures revealed that three Ca 2 + atoms are co-ordinated by the CBRs. Justifying our strategy, we noted a different pattern of Ca 2 + binding in Munc13-C2B [28] . Most notably, our data revealed that Asp To help interpret the hydrophobic-dependent membrane binding of PRF we used the structure of SmC2P1. These data revealed that the swing of the Asp 35 loop in SmC2P1 had a significant effect on one of the residues in analogous positions to the PRF hydrophobic residues discussed above ( Figures 6D-6F) . Notably, Leu 36 (Tyr 430 ) on CBR1 had shifted 5 Å towards the membrane-binding plane (Figures 6D-6F . Whereas all three of the latter residues represent relatively non-conservative amino acid substitutions, we noted that the backbone position of each residue remained essentially unaltered in the all of the structures considered (i.e. in apo-SmC2P1, Ca 2 + -bound SmC2P1 or the known structure of PRF itself). These data suggested that Ca 2 + did not induce significant conformational changes in any of these residues and only locks the Asp 35 (Asp 429 ) loop in a stable conformation.
Taken together, our structural and functional data (using three independent experimental settings) strongly suggested that, in the absence of Ca 2 + , both pairs of essential PRF C2 domain hydrophobic residues, W427A/Y430A and Y486A/W488A, are positioned in a sub-optimal conformation with respect to one another that precludes their interaction with the membrane. Our study on SmC2P1 suggested that the major Ca 2 + -driven movement in the C2 domain predominantly affected the position of Leu 36 (Tyr  430 ) . Accordingly, we noted that the PRF W427A/Y430A mutant had the greatest functional defects in the assays detailed above. With respect to the PRF Y486A/W488A mutant, we observed in SmC2P1 a small, but noticeable, movement in Phe 92 (Trp  488 ) ; however, we argue this modest shift is unlikely to be of primary importance in the context of membrane binding. Instead, we postulated that the global Ca 2 + -driven conformational change in CBR1 of PRF brings this entire loop into closer proximity with CBR3. Taken together, these two loops would form a striking groove. The predicted repositioning of Asp 429 in CBR1 of PRF would thus be anticipated to change the entire environment of CBR3. This would provide additional structural features to the PRF C2 domain, to promote an interaction between the aromatic side chains and the plasma membrane.
Binding to the plasma membrane does not induce irreversible changes in the PRF MACPF domain
Our functional studies on the C2 domain of PRF, together with structural studies on the PRF C2 domain-like protein SmC2P1, defined the localized effect of Ca 2 + on the C2 domain to explain the mechanism of PRF-membrane binding. We noted previously that patterns of conserved disulfide bonds linking the C2 domain to the MACPF domain (and in particular the TMH2 region) may represent a possible pathway through which Ca 2 + binding could directly trigger insertion of PRF into the phospholipid bilayer [9] . In the present study, other than repositioning of the Asp 35 loop into a stable conformation, we observed no major structural changes in SmC2P1. When rationalized in the context of the intact PRF molecule, the predicted movement of the C2 domain when Asp 429 binds Ca 2 + would be an unlikely mechanism for triggering irreversible conformational change in the PRF MACPF domain. We also noted that the increased thermal stability of WT PRF ( Figure 7A ) was entirely reversible through chelating Ca 2 + with EGTA, as measured by the reduction in the melting temperature to the basal (Ca 2 + -free) level. Furthermore, subsequent addition of excess Ca 2 + returned PRF to its more stable conformation ( Figure 7A ). These and earlier observations ( Figure 2B ) suggested that Ca 2 + binding did not cause irreversible unfurling of TMH1/TMH2 and PRF aggregation. Given these results, we investigated whether interactions between the PRF C2 domain and membranes directly promoted irreversible PRF membrane insertion.
In order to test whether PRF binding to the membrane caused conformational changes that resulted in membrane insertion, we needed to uncouple PRF binding from the events that led to pore formation. To investigate this, we exploited a unique feature of PRF. Unlike other MACPF proteins and CDCs (cholesterol-dependent cytolysins), membrane binding of PRF is dependent on elevated Ca 2 + and, critically, it is known that membrane binding is reversible [15] . If PRF binding to membranes resulted in substantial MACPF domain conformational change such as unravelling of the TMH β-hairpins [9] , then material recovered from membranes would be inactive, as has been demonstrated for other pore-forming toxins such as bacterial CDCs [31] . Alternatively, if membrane binding did not promote membrane insertion then we would be able to recover active PRF from the membrane-bound state.
To test these ideas, we designed our experiments so that the amount of PRF added to target cells would be insufficient to induce lysis (or form pores) (Figures 7B-7E ). Thus we titrated increasing amounts of target red blood cells to a fixed amount of PRF until minimal/no lysis was observed (i.e. pore formation was impaired through a decreased PRF/cell ratio). Through measuring cytolysis we determined the number of target SRBCs required for PRF to achieve a minimal and maximal cell lysis [i.e. 1.5×10 8 cells/ml (100 % lysis) and 40×10 8 cells/ml (no lysis) respectively ( Figure 7B) ].
We then added 2.8-14 ng of PRF to 40×10 8 cells/ml ( Figure 7C ; the 'primary bind'). This resulted in 0-20 % cytolysis depending on PRF concentration ( Figure 7F , open squares). The cells were washed three times using Ca 2 + -free buffer in order to elute membrane-bound PRF ( Figure 7C ). The supernatants were combined and added to 27-times fewer fresh SRBCs, 1.5×10 8 cells/ml ( Figure 7C , the 'secondary bind'). This resulted in a higher PRF/cell ratio and, as expected, not only allowed PRF to 'rebind' (Figure 7G ), but also to oligomerize and lyse the targets ( Figure 7F , open circles). As a positive control, we performed the 'primary bind' in the absence of Ca 2 + , thus preventing PRF from membrane binding and allowing the maximum cytolysis in the 'secondary bind' ( Figure 7D , and Figure 7F , closed circles). As a negative control, both the 'primary bind' and the washes were performed in the presence of Ca 2 + that prevented elution of PRF and, hence there was no lysis in the 'secondary bind' ( Figure 7E , and Figure 7F , crosses).
We found that, at higher PRF concentrations, the 'primary bind' resulted in up to 20% cell lysis, but in these instances the subsequent lysis in the 'secondary bind' experiments was reduced by the extent of the primary one ( Figure 7F , last point, arrowed). Remarkably, the sum of the primary and secondary lysis was essentially identical to the control ( Figure 7H , open circles), indicating a complete recovery of fully functional PRF following its initial membrane binding under conditions that would normally favour irreversible pore formation (37 • C, pH 7, 1 mM Ca 2 + ).
Overall, these results suggested that PRF membrane binding did not directly result in events that would be anticipated to be irreversible: TMH unwinding, membrane insertion and formation of the membrane-spanning β-barrel.
DISCUSSION
In the present study, we investigated the mechanism and the role of Ca 2 + binding in PRF activity. We supported our functional studies by determining the crystal structure of the apo and Ca 2 + -bound forms of SmC2P1. Dali and BLAST searches reveal that SmC2P1 (which comprises a C2 domain alone), is more similar to the PRF C2 domain than any other structure determined to date. By analogy, our structural data suggest that PRF can co-ordinate three Ca 2 + atoms within the CBRs, but that movement of the Asp 429 loop alone represents the major Ca 2 + -driven rearrangement in PRF. Critically, however, when considered with the results of functional studies, our data reveal that Ca 2 + -induced movement of the Asp 429 loop permits relative re-positioning of four key hydrophobic residues such that they can properly interact with the lipid membrane.
The C2 domain is one of the most common mammalian motifs to regulate membrane-associated signalling pathways. Most C2 domain proteins are activated by intracellular Ca 2 + signals, which drives docking of the proteins to specific membranes predominantly through electrostatic and/or hydrophobic interactions [32] . For example, the PKC-α (protein kinase Cα) C2 domain binds to anionic headgroups of PS (phosphatidylserine) and PIP 2 (phosphatidylinositol 4,5-bisphosphate) through electrostatic interactions [33] , whereas docking of the cPLA 2 α (cytosolic phospholipase A 2 α) C2 domain is triggered by electrostatic interactions with subsequent penetration of hydrophobic residues into PC (phosphatidylcholine)-rich membranes [34] . In comparison with other C2 domains, however, membrane binding through the C2 domain of PRF is unusual. PRF requires up to 1000-fold higher concentrations of Ca 2 + to restrict its activity to the extracellular milieu [11] , and, as shown in the present study, membrane binding is regulated by Ca 2 + -induced conformational changes that permit subsequent hydrophobic interactions with the plasma membrane. Furthermore, despite the significant variation in the phospholipid composition of plasma membranes between cell types [35, 36] , PRF binding and cell lysis have evolved to be apparently indiscriminate of membrane composition [37] . This is fundamentally important for host immune defence, and allows post-hoc analysis; *P < 0.05. (B) We determined the number of SRBCs that were required for minimal and maximal lysis of WT PRF in HE buffer supplemented with 1 mM Ca 2 + at 37 • C. We allowed PRF to first bind to membranes at 4 • C for 10 min (a non-permissive temperature that prevents rapid oligomerization), and the solution was subsequently warmed to 37 • C for 15 min, to permit oligomerization and cell lysis. We found that a minimum of 1.5×10 8 cells/ml resulted in 100 % lysis and a maximum of 40×10 8 cells/ml resulted in no lysis. Each value represents means + − S.E.M. for three independent experiments. (C) WT PRF (2.8-14 ng) was added to 40×10 8 cells/ml of SRBCs in HE buffer containing 1 mM Ca 2 + , to a final volume of 1 ml. PRF was bound to membranes at 4 • C for 10 min, with subsequent warming to 37 • C for 15 min (primary bind); cell lysis was assessed by haemoglobin release. The WT PRF bound to SRBCs was then washed off with four washes of 200 μl of Ca 2 + -free HE buffer. Fresh SRBCs (1.5×10 8 cells/ml) (secondary bind) were subsequently added to the combined supernatant at 4 • C; the mixture was supplemented with 1 mM Ca 2 + and incubated for 10 min to allow PRF to bind to SRBCs. The cell suspension was subsequently warmed to 37 • C (15 min) and lysis was measured. Supernatant containing haemoglobin released from lysed cells in the primary bind was diluted 27-fold to account for the difference in cell number in the secondary bind (40×10 8 and 1.5×10 8 cells/ml respectively). (D) As a negative control, the same experiment was repeated; however, the primary bind of WT PRF was washed with 200 μl of HE buffer plus 1 mM Ca 2 + (four times). Washing in the presence of 1 mM Ca 2 + prevented WT PRF from being removed from SRBCs, and consequently there was no PRF present in the secondary bind. (E) As a positive control, the same experiment was repeated, but the primary bind of WT PRF was conducted in the absence of Ca 2 + thus precluding PRF from specific Ca 2 + -dependent membrane binding; the supernatant containing unbound PRF was removed and used in the secondary bind. (F) An SRBC lysis assay showing that after binding to 40×10 8 cells/ml in the presence of 1 mM Ca 2 + at 37 • C (primary bind), WT PRF remained active when washed off with Ca 2 + -free buffer and then added to 1.5×10 8 cells/ml in the presence of 1 mM Ca 2 + at 37 • C (secondary bind). Haemoglobin-containing supernatant from the primary bind was diluted 27-fold to account for the difference in cell number between the primary and secondary bind (40×10 8 and 1.5×10 8 cells/ml respectively). Each value represents means + − S.E.M. for at least three independent experiments and statistics were obtained with an unpaired two-sample for means t test; *P < 0.05. (G) Western immunoblot using 11.2 ng PRF (corresponding to the second highest amount used in Figure 7F ). Upper panel, PRF bound to 40×10 8 cells/ml in the presence of 1 mM Ca 2 + (primary bind, as per Figure 7C ) or in the absence of Ca 2 + (positive control, as per Figure 7D ). Lower panel, secondary bind of PRF eluted from the primary bind or remaining in the supernatant (S/N) in the positive control, to 1.5×10 8 cells/ml in the presence of 1 mM Ca 2 + . (H) Comparison between the percentage lysis of the positive control (no added Ca 2 + in the primary bind) and the experiment (1 mM Ca 2 + in the primary bind followed by Ca 2 + -free washes), where supernatants from the primary and secondary binds were added together (the supernatant from the primary bind was diluted as described in Figure 7F ).
PRF to lyse target cells from differentiated organisms, spanning insects (e.g. Sf9 cells) to humans [20] .
Interestingly, mutation of either the CBR1 or CBR3 hydrophobic residues (W427A/Y430A or Y486A/W488A respectively) impaired binding of PRF to the plasma membrane. Furthermore, even membrane-bound mutant proteins did not oligomerize and form pores efficiently in comparison with equal amounts of bound WT PRF. This suggested that the loss of hydrophobic moieties on either CBR1 or CBR3 could influence the topology of bound monomers, thus impairing their capacity to oligomerize efficiently. Recent studies have revealed that PRF shares structural homology with bacterial CDCs, with a common MACPF domain and C2/immunoglobulin membrane-binding domain folds [8] . These data suggested that, similar to the mechanism reported for the hydrophobic membrane binding loops of bacterial CDCs, the four bulky hydrophobic residues of PRF anchor the protein in an orientation that promotes oligomerization [38] .
The present study has revealed that the major role of the C2 domain is limited to PRF binding to the target cell membrane. We hypothesize that subsequent interactions at the membrane surface, such as PRF monomer-monomer contact, are instead likely to be responsible for triggering the major conformational changes that culminate in TMH unwinding, membrane insertion and formation of the membrane-spanning β-barrel. Of interest, this mechanism of pore formation has also been proposed for bacterial CDCs, although comparison of the crystal structures and electron microscopy structures of CDC and PRF pore forms has revealed distinct differences [9] . CDCs oligomerize to form a pre-pore, which subsequently collapses in order to bring the transmembrane α-helices close enough to insert and span the bilayer [39, 40] . It is unknown, however, whether PRF forms a pre-pore, as the TMH regions of PRF are approximately twice as long as those of CDCs, and consequently PRF does not appear to collapse during pore formation [9] . Future studies will therefore be directed at elucidating the exact mechanism of PRF TMH release, membrane insertion and pore formation within the immunological synapse.
In conclusion, we have determined the structural and functional basis for the first and essential step of cytotoxic lymphocytes effector mechanism: PRF binding to the target cell membrane. Our data demonstrated that the role of the PRF C2 domain appears to be limited to anchoring the protein to the target membrane. We further suggest that Ca 2 + likely triggers a single localized conformational change in the Asp 429 loop of PRF. The consequence of this change is, however, to activate the molecule with respect to membrane binding. Finally, we showed that Ca 2 + binding alone does not trigger irreversible PRF oligomerization or indeed insertion into the membrane. Together, our observations highlight the specialized and unique regulation of PRF pore formation, which has evolved to provide the immune system with an exquisitely efficient cytotoxic effector molecule.
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